Skip to main content

Hearing Loss, Cochlear

0
Pipeline Programs
3
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Oticon
OticonDenmark - Smørum
4 programs
Experiment 1N/A1 trial
Hearing Aid Noise Reduction - OffN/A
NeuristimN/A1 trial
S0N0N/A1 trial
Active Trials
NCT04010721Completed20Est. Aug 2020
NCT02948790Completed17Est. Apr 2019
NCT04357704Withdrawn0Est. Sep 2019
iotaMotion
iotaMotionIA - Iowa City
1 program
Cochlear Implantation with Robotic-Assisted Insertion SystemN/A1 trial
Active Trials
NCT06664697Recruiting50Est. Dec 2025
Purdue Pharma
Purdue PharmaCT - Stamford
1 program
Hearing Aid Noise Reduction - OffN/A1 trial
Active Trials
NCT07287774Recruiting50Est. Apr 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Purdue PharmaHearing Aid Noise Reduction - Off
iotaMotionCochlear Implantation with Robotic-Assisted Insertion System
OticonExperiment 1
OticonS0N0
OticonNeuristim

Clinical Trials (5)

Total enrollment: 137 patients across 5 trials

NCT07287774Purdue PharmaHearing Aid Noise Reduction - Off

Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids

Start: Oct 2025Est. completion: Apr 202650 patients
N/ARecruiting
NCT06664697iotaMotionCochlear Implantation with Robotic-Assisted Insertion System

Post-Market Clinical Investigation of the IotaSOFT Insertion System

Start: Oct 2024Est. completion: Dec 202550 patients
N/ARecruiting
NCT04010721OticonExperiment 1

Effects of Pulses on Loudness

Start: Feb 2020Est. completion: Aug 202020 patients
N/ACompleted

Improved Speech Recognition Performance in Noise by Encoding Binaural Spatial Cues to the Cochlear Implant User.

Start: Apr 2019Est. completion: Sep 20190
N/AWithdrawn

Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma

Start: Apr 2017Est. completion: Apr 201917 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 137 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.